• 01 July, 2025

Merck Life Science inks MoU with Genext Genomics

November 19, 2024 | Tuesday | News

Combining local expertise with global biomanufacturing capabilities

Merck Life Science in India has signed a Memorandum of Understanding (MoU) with GeNext Genomics, an emerging biotech company.

The MoU was signed between Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr Ashwin Kashikar, Managing Director, Genext Genomics; Supriya Kashikar, Founder & CEO, GeNext Genomics and Ravi Kashikar, Chairman and Founder of Ankur Seeds.

This collaboration creates a unique competitive edge by combining local expertise with global biomanufacturing capabilities. By partnering with Merck for their world-class expertise in biomanufacturing, Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India advancing affordable indigenous immunotherapies

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy